# A Study of Concurrent Chemoradiation With Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

> **NCT04636762** · PHASE2 · COMPLETED · sponsor: **Second Xiangya Hospital of Central South University** · enrollment: 40 (actual)

## Conditions studied

- Extensive-stage Small Cell Lung Cancer

## Interventions

- **PROCEDURE:** Radiation Therapy

## Key facts

- **NCT ID:** NCT04636762
- **Lead sponsor:** Second Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-01
- **Primary completion:** 2022-05-01
- **Final completion:** 2022-05-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04636762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04636762, "A Study of Concurrent Chemoradiation With Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04636762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*